Work

Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial

Year: 2013

Type: article

Source: American Heart Journal

DOI: 10.1016/j.ahj.2013.08.012

Authors: Roberto Latini, Lidia Staszewsky, Jie-Lena Sun, M. Angelyn Bethel, Marcello Disertori, Steven M. Haffner, Rury R. Holman, Futien Chang, Thomas D. Giles, Aldo P. Maggioni, Guy E.H.M. Rutten, Eberhard Standl, Laine Thomas, Gianni Tognoni, Robert M. Califf, John J.V. McMurray

Institutions: Duke Medical Center, Duke Clinical Research Institute, University of Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism, Ospedale Santa Chiara, Baylor College of Medicine, National Taiwan University Hospital, Tulane University, Associazione Nazionale Medici Cardiologi Ospedalieri, University Medical Center Utrecht, Mario Negri Sud Foundation, British Heart Foundation, University of Glasgow

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2117701738

FWCI: 2.04

Cites: 26

Cited by: 46

Related to: 10